Hepatic adverse effects of fructose consumption independent of overweight/obesity

International Journal of Molecular Sciences

Volumn 14, Issue 11, 2013, Pages 21873-21886

  Schultz, Alini ^a   Neil, Debora ^a   Aguila, Marcia B ^a   Mandarim de Lacerda, Carlos A ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

High fat diet; High fructose diet; Insulin resistance; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

CHOLESTEROL; FRUCTOSE; GLUCOSE TRANSPORTER 2; INSULIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BODY MASS; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FOOD COMPOSITION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; IMMUNOBLOTTING; INSULIN RESISTANCE; INTRAPERITONEAL GLUCOSE TOLERANCE TEST; LIPID DIET; LIPOGENESIS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DIET, HIGH-FAT; FATTY LIVER; FRUCTOSE; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MICE; OBESITY; OVERWEIGHT;

EID: 84887170599     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141121873     Document Type: Article

References (38)

1. Murphy, S. P.; Johnson, R. K. The scientific basis of recent US guidance on sugars intake. Am. J. Clin. Nutr. 2003, 78, 827S-833S.
2. Lim, J. S.; Mietus-Snyder, M.; Valente, A.; Schwarz, J. M.; Lustig, R. H. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 2010, 7, 251-264.
3. Nomura, K.; Yamanouchi, T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J. Nutr. Biochem. 2012, 23, 203-208.
4. Aeberli, I.; Hochuli, M.; Gerber, P. A.; Sze, L.; Murer, S. B.; Tappy, L.; Spinas, G. A.; Berneis, K. Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: A randomized controlled trial. Diabetes Care 2013, 36, 150-156.
5. Lustig, R. H.; Schmidt, L. A.; Brindis, C. D. Public health: The toxic truth about sugar. Nature 2012, 482, 27-29.
6. Tsuchiya, H.; Ebata, Y.; Sakabe, T.; Hama, S.; Kogure, K.; Shiota, G. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice. Metabolism 2013, 62, 62-69.
7. Kim, C. H.; Younossi, Z. M. Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome. Clevel. Clin. J. Med. 2008, 75, 721-728.
8. Schultz, A.; Mendonca, L. S.; Aguila, M. B.; Mandarim-de-Lacerda, C. A. Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease. Exp. Toxicol. Pathol. 2012, 64, 273-282.
9. Tappy, L.; Le, K. A.; Tran, C.; Paquot, N. Fructose and metabolic diseases: New findings, new questions. Nutrition 2010, 26, 1044-1049.
10. Abdelmalek, M. F.; Lazo, M.; Horska, A.; Bonekamp, S.; Lipkin, E. W.; Balasubramanyam, A.; Bantle, J. P.; Johnson, R. J.; Diehl, A. M.; Clark, J. M.; et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 2012, 56, 952-960.
11. Janevski, M.; Ratnayake, S.; Siljanovski, S.; McGlynn, M. A.; Cameron-Smith, D.; Lewandowski, P. Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat. Food Funct. 2012, 3, 141-149.
12. Coate, K. C.; Smith, M. S.; Shiota, M.; Irimia, J. M.; Roach, P. J.; Farmer, B.; Williams, P. E.; Moore, M. C. Hepatic glucose metabolism in late pregnancy: Normal versus high-fat and-fructose diet. Diabetes 2013, 62, 753-761.
13. Bezerra, R. M.; Ueno, M.; Silva, M. S.; Tavares, D. Q.; Carvalho, C. R.; Saad, M. J. A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J. Nutr. 2000, 130, 1531-1535.
14. Delarue, J.; Normand, S.; Couet, C.; Pachiaudi, C.; Urbain, C.; Lamisse, F.; Riou, J. P. Effects of free fatty acids on the metabolic response to oral fructose in lean healthy humans. Int. J. Obes. Relat. Metab. Disord. 1996, 20, 130-136.
15. McGarry, J. D. Malonyl-CoA and carnitine palmitoyltransferase I: An expanding partnership. Biochem. Soc. Trans. 1995, 23, 481-485.
16. Kawasaki, T.; Igarashi, K.; Koeda, T.; Sugimoto, K.; Nakagawa, K.; Hayashi, S.; Yamaji, R.; Inui, H.; Fukusato, T.; Yamanouchi, T. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J. Nutr. 2009, 139, 2067-2071.
17. Moran-Salvador, E.; Lopez-Parra, M.; Garcia-Alonso, V.; Titos, E.; Martinez-Clemente, M.; Gonzalez-Periz, A.; Lopez-Vicario, C.; Barak, Y.; Arroyo, V.; Claria, J. Role for PPAR-γ in obesity-induced hepatic steatosis as determined by hepatocyte-and macrophage-specific conditional knockouts. FASEB J. 2011, 25, 2538-2550.
18. Schadinger, S. E.; Bucher, N. L.; Schreiber, B. M.; Farmer, S. R. PPAR-γ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 2005, 288, E1195-E1205.
19. Caton, P. W.; Nayuni, N. K.; Khan, N. Q.; Wood, E. G.; Corder, R. Fructose induces gluconeogenesis and lipogenesis through a SIRT1-dependent mechanism. J. Endocrinol. 2011, 208, 273-283.
20. Valera, A.; Pujol, A.; Pelegrin, M.; Bosch, F. Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 1994, 91, 9151-9154.
21. Guillemain, G.; Loizeau, M.; Pincon-Raymond, M.; Girard, J.; Leturque, A. The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells. J. Cell. Sci. 2000, 113, 841-847.
22. Okamoto, Y.; Tanaka, S.; Haga, Y. Enhanced GLUT2 gene expression in an oleic acid-induced in vitro fatty liver model. Hepatol. Res. 2002, 23, 138-144.
23. Yamamoto, T.; Fukumoto, H.; Koh, G.; Yano, H.; Yasuda, K.; Masuda, K.; Ikeda, H.; Imura, H.; Seino, Y. Liver and muscle-fat type glucose transporter gene expression in obese and diabetic rats. Biochem. Biophys. Res. Commun. 1991, 175, 995-1002.
24. Alisi, A.; Manco, M.; Pezzullo, M.; Nobili, V. Fructose at the center of necroinflammation and fibrosis in nonalcoholic steatohepatitis. Hepatology 2011, 53, 372-373.
25. Francini, F.; Castro, M. C.; Schinella, G.; Garcia, M. E.; Maiztegui, B.; Raschia, M. A.; Gagliardino, J. J.; Massa, M. L. Changes induced by a fructose-rich diet on hepatic metabolism and the antioxidant system. Life Sci. 2010, 86, 965-971.
26. Farrell, G. C.; Larter, C. Z. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006, 43, S99-S112.
27. Yoshiike, N.; Lwin, H. Epidemiological aspects of obesity and NASH/NAFLD in Japan. Hepatol. Res. 2005, 33, 77-82.
28. Malhi, H.; Gores, G. J. Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin. Liver Dis. 2008, 28, 360-369.
29. Day, C. P. Pathogenesis of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 2002, 16, 663-678.
30. Day, C. P.; James, O. F. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998, 114, 842-845.
31. Kohli, R.; Kirby, M.; Xanthakos, S. A.; Softic, S.; Feldstein, A. E.; Saxena, V.; Tang, P. H.; Miles, L.; Miles, M. V.; Balistreri, W. F.; et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010, 52, 934-944.
32. Takahashi, Y.; Soejima, Y.; Fukusato, T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J. Gastroenterol. 2012, 18, 2300-2308.
33. Institute of Laboratory Animal Resources (US). Guide for the Care and Use of Laboratory Animals; National Academy Press: Washington, DC, USA, 1996.
34. Reeves, P. G.; Nielsen, F. H.; Fahey, G. C., Jr. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939-1951.
35. Matthews, D. R.; Hosker, J. P.; Rudenski, A. S.; Naylor, B. A.; Treacher, D. F.; Turner, R. C. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412-419.
36. Catta-Preta, M.; Mendonca, L. S.; Fraulob-Aquino, J.; Aguila, M. B.; Mandarim-de-Lacerda, C. A. A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies. Virchows Arch. 2011, 459, 477-485.
37. Aguila, M. B.; Pinheiro, A. R.; Parente, L. B.; Mandarim-de-Lacerda, C. A. Dietary effect of different high-fat diet on rat liver stereology. Liver Int. 2003, 23, 363-370.
38. Santos, C. F.; Souza-Mello, V.; Faria, T. S.; Mandarim-de-Lacerda, C. A. Quantitative morphology update: Image analysis. Int. J. Morphol. 2013, 31, 23-30.